Madridge Journal of Cancer Study & Research

ISSN: 2640-5180

Scientific Session Abstracts

2nd International Cancer Study & Therapy Conference
Feb 20-22, 2017, Baltimore, USA

The presence of breast cancer related proteins in saliva

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Charles F. Streckfus

Is molecular breast imaging an appropriate modality for breast cancer screening?

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Tanya W. Moseley, Gaiane M. Rauch, Beatriz E. Adrada

A prospective study of chemo-predictive assay for targeting cancer stem cells in Glioblastoma patients

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Pier Paolo Claudio, Candace M. Howard, Anthony Alberico, Linda Brow, Krista Dennin, and Jagan Valluri

Giant obscurins act upstream of the PI3K/Akt pathway in breast epithelial cells

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Aikaterini Kontrogianni-Konstantopoulos

The possible involvement of Epstein–Barr Virus in the etiology of leukemia in Sudanese patients

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Haitham E Elawad, Shamsoun K Kafi, Ismail Abd Elrahman, Salaheldein G Elzaki, Abuelgasim Eljaili, Mohammed E Ornasir and Mohammed Y Elamir

p65BTK is a novel therapeutic target in p53-null drug-resistant colon cancers

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Emanuela Grassilli, Leonarda Ianzano,Sara Bonomo, Annamaria Cialdella, Fabio Pisano, Maria Grazia Cerrito, Carola Missaglia, Chelsea McLean, Gabriele Romano, Roberto Giovannoni, Marco Agostini, Donato Nitti, Emile Voest, Kristian Helin and Marialuisa Lavitrano

Cytotoxic activity of fractions Stenocereus griseus H on HeLa cell lines

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Rafael Silva Torres, Lourdes López Rangel and Paula Figueroa Arredondo

Targeting BCL6 for the treatment of DLBCL using the Site Identification by Ligand Competitive Saturation (SILCS) technology

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Alexander D. MacKerell, Jr., Mariano G Cardenas, Wenbo Yu, Wendy Beguelin, Matthew R Teater, Huimin Geng , Rebecca L. Goldstein, Erin Oswald, Katerina Hatzi, Shao-Ning Yang, Joanna Cohen, Rita Shaknovich, Huimin Cheng, Dongdong Liang, Hyo Je Cho, Joshua Abbott, Wayne Tam, John P. Leonard, Leandro Cerchietti, Tomasz Cierpicki, Fengtian Xue and Ari M. Melnick

Seeking novel anticancer strategies around the druggable clock

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Blazevits Olga, Vecchio Donatella, Allavena Giulia, Parodi Chiara, Ferrari Alessio, Guijarro Ana, De Mei Claudia and Grimaldi Benedetto

Regulation of HIF1α expression by a natural compound; a new hnRNP involvement

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Bo Yeon Kim, Yukihiro Asami, Nak Kyun Soung, Hae Min Kim, Jae Hyuk Jang, N.R. Themmegowda, Jong Seog Ahn and Kyung Lee

A new druggable site to rescue p53 folding and activity

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Karen R. Khar, Atul Ranjan, Mark Fisher, Tomoo Iwakuma, and John Karanicolas

HER2-targeted extracellular vesicles delivery of therapeutic mRNA for enzyme prodrug therapy

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): AC Matin, Jing-Hung Wang, Masako Harada, Alain Delcayre,Travis Antes, Archana Gupta,MasamitsuKanada, Carol Green, Stefanie Jeffrey, Mark Pegram and Christopher Contag

Developing precision therapies for glioblastoma by targeting glioblastoma stem cells

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Pratik Kanabur, Sujuan Guo, Gary R Simonds, Deborah F. Kelly, Robert G Gourdie, Scott S Verbridge and Zhi Sheng

ElastofibromaDorsi (ED): Oncological significance and impact on management

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Mohamed Elshikh, Naveen Garg , Jesse Rayan, Peter Wei, Ahmed Elsayes and Bilal Mujtaba

Potential clinical implications of breast tumor kinase in ER-positive breast cancers

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Kiven E. Lukong, Sayem Miah and Gerald Davies

Epigenetic rewiring of breast cancer by targeting a metabolic switch

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Jung S. Byun, Sam Park, Dae Ik Yi, Genqing Liang, Marc Nicklaus, Megan L. Peach, Laura Guasch Pamies, Binwu Tang, Lalage M. Wakefield, Mohamed Kabbout and Kevin Gardner

Normal and cancer stem cells

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Chaker Adra

Targeting cancer stem cells in urothelial cancer enhances chemotherapeutic response

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Mohammad Obaidul Hoque, Akira Ooki, Asma Begum,Zeshaan A Rasheed and David Sidransky

Andrographolide inhibits angiogenesis and induces tumor suppressor gene RASSF1A expression in colon cancer cells

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Aditi Banerjee, Vivekjyoti Banerjee, Steven J. Czinn and Thomas G. Blanchard

Growth, migration, and stress: Filling in the “gap”

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Shoshanna N. Zucker

The cancer stem cells generate the components for the constitution of the supporting tissues in cancer

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Tie Chen, Chuanwen Fan, Ran Lu, Wenqi Shangguan, Xiaolong Chen, Yuan Liu, Wentong Meng, Hong Xu, Zongguang Zhou, Jiankun Hu and Xianming Mo

Restoration of Ikaros tumor suppressor function as a novel therapeutic approach for high-risk pediatric acute lymphoblastic leukemia

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Sinisa Dovat, Chunhua Song, Chandrika Gowda, Yali Ding, Malika Kapadia, Jonathon L. Payne and Mario Soliman

Survivin governs mitochondrial health by regulating the availability of phosphatidylethanolamine, PE

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Amelia Townley, Lucia Dunajovà, Denise McLean, Sophie Rochette and Sally P. Wheatley

Synergistic effects of oncolytic virotherapy in a bortezomib resistant syngeneic mouse model of multiple myeloma is mediated via immune modulation

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Chandini Thirukkumaran, Zhong-Qiao Shi, Jerry Nuovo, Joanne Luider, Karen Kopciuk, Marta Chesi۴, Leif Bergsagel۴, Yuan Dong, Ahmed Mostafa, Kathy Gratton, Satbir Thakur and Don Morris

T cell exhaustion is reinforced by progressive De novo DNA methylation programming

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Hazem Ghoniem, Hossam Abdelsamed, Yiping Fan, Robert Carter, Pranay Dogra, and Ben Youngblood

Metarrestin effectively disassembles PNCs and inhibits metastasis

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Chen Wang, Kevin Frankowski, Teper Yaroslav, SamarjitPatnaik, Frank Schoenen, Steve Titus, Lesley Griner, Noel Southall, Christopher Dextras, Jamey Sultan, IrawatiKandela, MarzenaLewandowska, Yi-ping Wen, John Norton, Wei Sun, Andrew Mazar, Jeffrey Aubé, Wei Zheng, Marc Ferrer, Udo Rudloff, Juan Jose Marugan and Sui Huang

Novel approaches based on immune checkpoints for cancer immunotherapy

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): Jorge Augusto Borin Scutti

Body mass index as a prognostic feature in breast cancer

Madridge J Cancer Stud Res. 2017

DOI: 10.18689/2640-5180.a2.002

Author(s): I. N. Bondarenko1 and Hojouj Mohammad